Monocyte angiotensin converting enzyme expression may be associated with atherosclerosis rather than arteriosclerosis in hemodialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 3, 2011, Pages 505-511

  Ulrich, Christof ^a   Seibert, Eric ^a   Heine, Gunnar H ^b   Fliser, Danilo ^b   Girndt, Matthias ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DIPEPTIDYL CARBOXYPEPTIDASE; HEMOGLOBIN A1C;

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; DIABETES MELLITUS; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; FLOW CYTOMETRY; HEMODIALYSIS; HUMAN; HUMAN CELL; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MORTALITY; PERITONEAL DIALYSIS; PREVALENCE; PROTEIN EXPRESSION; PULSE PRESSURE;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; ARTERIOSCLEROSIS; ATHEROSCLEROSIS; BLOOD PRESSURE; CAROTID ARTERY DISEASES; FEMALE; FLOW CYTOMETRY; GERMANY; GPI-LINKED PROTEINS; HUMANS; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; MALE; MIDDLE AGED; MONOCYTES; PEPTIDYL-DIPEPTIDASE A; PROSPECTIVE STUDIES; PULSATILE FLOW; RECEPTORS, IGG; RENAL DIALYSIS;

EID: 79953016393     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06870810     Document Type: Article

References (33)

1. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32: S112-S119, 1998 (Pubitemid 28527268)
2. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58: 353-362, 2000 (Pubitemid 30429882)
3. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336: 973-979, 1997 (Pubitemid 27152782)
4. Ross R: Atherosclerosis - An inflammatory disease. N Engl J Med 340: 115-126, 1999
5. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55: 648-658, 1999 (Pubitemid 29082891)
6. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimburger O, Cederholm T, Girndt M: IL-10, IL-6, and TNF-alpha: Central factors in the altered cytokine network of uremia - The good, the bad, and the ugly. Kidney Int 67: 1216-1233, 2005 (Pubitemid 40463099)
7. Mönckeberg JG: Ueber knochenbildung in der arterienwand. Virchows Arch 167: 191-210, 1902
8. Tyralla K, Amann K: Morphology of the heart and arteries in renal failure. Kidney Int Suppl 84: S80-S83, 2003 (Pubitemid 36513382)
9. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103: 987-992, 2001 (Pubitemid 32183805)
10. Ziegler-Heitbrock HWL: Heterogeneity of human blood monocytes: The CD14+ CD16+ subpopulation. Immunol Today 17: 424-428, 1996
11. Heine GH, Ulrich C, Seibert E, Seiler S, Marell J, Reichart B, Krause M, Schlitt A, Köhler H, Girndt M: CD14(++)CD16(+) monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int 73: 622-629, 2008 (Pubitemid 351264115)
12. Ribichini F, Pugno F, Ferrero V, Bussolati G, Feola M, Russo P, Di MC, Colombo A, Vassanelli C: Cellular immunostaining of angiotensin-converting enzyme in human coronary atherosclerotic plaques. J Am Coll Cardiol 47: 1143-1149, 2006
13. Diet F, Pratt RE, Berry GJ, Momose N, Gibbons GH, Dzau VJ: Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 94: 2756-2767, 1996 (Pubitemid 26411739)
14. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG: Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916- 1923, 1996
15. Rogacev KS, Ulrich C, Blomer L, Hornof F, Oster K, Ziegelin M, Cremers B, Grenner Y, Geisel J, Schlitt A, Kohler H, Fliser D, Girndt M, Heine GH: Monocyte heterogeneity in obesity and subclinical atherosclerosis. Eur Heart J 31: 369-376, 2010
16. Ulrich C, Heine GH, Gerhart MK, Köhler H, Girndt M: Proinflammatory CD14+CD16+ monocytes are associated with subclinical atherosclerosis in renal transplant patients. Am J Transplant 8: 103-110, 2008
17. Schlitt A, Heine GH, Blankenberg S, Espinola-Klein C, Dopheide JF, Bickel C, Lackner KJ, Iz M, Meyer J, Darius H, Rupprecht HJ: CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb Haemost 92: 419-424, 2004 (Pubitemid 39172323)
18. Rogacev KS, Ziegelin M, Ulrich C, Seiler S, Girndt M, Fliser D, Heine GH: Haemodialysis-induced transient CD16+ monocytopenia and cardiovascular outcome. Nephrol Dial Transplant 24: 3480-3486, 2009
19. Ulrich C, Heine GH, Seibert E, Fliser D, Girndt M: Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease. Nephrol Dial Transplant 25: 2265-2272, 2010
20. Klassen PS, Lowrie EG, Reddan DN, DeLong ER, Coladonato JA, Szczech LA, Lazarus JM, Owen WF Jr: Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 287: 1548-1555, 2002 (Pubitemid 34270000)
21. Wang M, Monticone RE, Lakatta EG: Arterial aging: A journey into subclinical arterial disease. Curr Opin Nephrol Hypertens 19: 201-207, 2010
22. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353: 238-248, 2005 (Pubitemid 41058323)
23. Fellstrom BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Gronhagen-Riska C, de Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Suleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wuthrich RP, Gottlow M, Johnsson E, Zannad F: Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 360: 1395-1407, 2009
24. London GM: Controversy on optimal blood pressure on haemodialysis: Lower is not always better. Nephrol Dial Transplant 16: 475-478, 2001
25. Honda H, Qureshi AR, Heimburger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B: Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 47: 139-148, 2006 (Pubitemid 41828276)
26. Pecoits-Filho R, Barany P, Lindholm B, Heimburger O, Stenvinkel P: Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17: 1684-1688, 2002 (Pubitemid 35012175)
27. Porazko T, Kuzniar J, Kusztal M, Kuzniar TJ, Weyde W, Kuriata-Kordek M, Klinger M: Increased aortic wall stiffness associated with low circulating fetuin A and high C-reactive protein in predialysis patients. Nephron Clin Pract 113: c81-c87, 2009
28. Ohkuma T, Minagawa T, Takada N, Ohno M, Oda H, Ohashi H: C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients. Am J Kidney Dis 42: 355-361, 2003 (Pubitemid 36944445)
29. Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55: 1899-1911, 1999
30. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, Sarnacki S, Cumano A, Lauvau G, Geissmann F: Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317: 666-670, 2007 (Pubitemid 47229966)
31. Gottsäter A, Forsblad J, Matzsch T, Persson K, Ljungcrantz I, Ohlsson K, Lindgarde F: Interleukin-1 receptor antagonist is detectable in human carotid artery plaques and is related to triglyceride levels and Chlamydia pneumoniae IgA antibodies. J Intern Med 251: 61-68, 2002 (Pubitemid 34209075)
32. Schieffer B, Schieffer E, Hilfiker-Kleiner D, Hilfiker A, Kovanen PT, Kaartinen M, Nussberger J, Harringer W, Drexler H: Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: Potential implications for inflammation and plaque instability. Circulation 101: 1372-1378, 2000 (Pubitemid 30169857)
33. Guerrero A, Montes R, Munoz-Terol J, Gil-Peralta A, Toro J, Naranjo M, Gonzalez-Perez P, Martin-Herrera C, Ruiz-Fernandez A: Peripheral arterial disease in patients with stages IV and V chronic renal failure. Nephrol Dial Transplant 21: 3525-3531, 2006 (Pubitemid 44817104)